BASROC/CONFORM OPEN DAY 2009 At STFC Cockroft Institute Daresbury Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology.

Slides:



Advertisements
Similar presentations
Heavy Ion Cancer Therapy
Advertisements

CARBON ION THERAPY FOR SACRAL CHORDOMAS
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Experience, Expertise and a Commitment to Excellence™
D.G.Lewis Department of Medical Physics Velindre Cancer Centre Whitchurch, Cardiff RT-GRID: Grid Computing for Radiotherapy.
Dose Calculations A qualitative overview of Empirical Models and Algorithms Hanne Kooy.
University of Florida, Jacksonville, FL
An Advanced Linear Accelerator Facility for Microelectronic Dose Rate Studies P.E. Sokol and S.Y.Lee Indiana University.
Radiation Exposure, Dose and Relative Biological Effectiveness in Medicine Background Image:
Some remaining questions in particle therapy radiation biology Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology 2.
Analysis and Control of Beam Dynamics in EMMA Kai Hock and Andy Wolski STFC PPRP Meeting, Glasgow, 24 June 2009.
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Welcome! BASROC/CONFORM Open Day Daresbury May 11 th 2009 Roger Barlow, Manchester University and the Cockcroft Institute.
Radiation Protection in Radiotherapy
Radiotherapy for Brain Tumours What do I need to know? Dr Matthew Foote Radiation Oncologist Princess Alexandra Hospital Queensland.
Part 1 Introduction to Radiotherapy and External Beam Radiation Deepak Khuntia, MD Vice President, Medical Affairs Varian Medical Systems.
Radiation oncology at JINR in brief Dzhelepov Laboratory of Nuclear Problems Joint Institute for Nuclear Research, Dubna, Russia  Accelerator technique.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
The Particle Therapy Cancer Research Institute is a member of Introduction to Proton Therapy JAI Octoberfest, 3 rd October 2014 Claire Timlin Particle.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme PAMELA: Concepts Particle Accelerator for MEdicaL Applications K.Peach(JAI,
Radiotherapy for Kidney cancer
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
Report from WP4: Applications of Accelerators AccApplic  Accelerator Applications  Aims of WP4  Workshops so far  Future workshops  Status  Plans.
The Skandion clinic, plans for the use of particle beams for radiation therapy in Sweden presented by Erik Grusell, medical radiation physicist Dept of.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme Charged Particle Therapy Treating cancer with protons and light ions Ken Peach,
FFAG Fixed Field Alternating Gradient synchrotrons, FFAGs, combine some of the main advantages of both cyclotrons and synchrotrons:  Fixed magnetic field.
Charged Particle Therapy: Physicists meet Physicians Ken Peach John Adams Institute for.
British Accelerator Science & Radiation Oncology Consortium A new.
A Laser Afternoon: Introduction Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin.
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
Using Radiation in Medicine. There are 3 main uses of radiation in medicine: Treatment Diagnosis Sterilization.
The CONFORM project Roger Barlow BASROC launch 3 rd May 2007.
Training Module 3 – Version 1.1 For Internal Use Only ® Radiation Therapy 
Cancer Therapy and Imaging Cancer Therapy and Imaging Rob Edgecock STFC Rutherford Appleton Laboratory.
CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.
Applications of particle accelerators outside particle physics Ken Peach APPEAL 2 Oxford 2 nd July 2011.
JAI-Diamond Joint Seminar 07/06/20071 Development of Non-Scaling FFAG : EMMA & PAMELA Takeichiro Yokoi J. Adams Institute Oxford University.
FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a wide variety of applications Cancer Therapy and UK Activities.
NEUTRINO DETECTORS Cutting-Edge Accelerator Research for a Neutrino Factory and Other Applications Ajit Kurup for the FETS and UKNF Collaborations Cutting-Edge.
3 Medical uses of Radiation
ENLIGHT,12/2/20021 Health and Science, can CERN contribute? The Mission of CERN (1954): “The Organization shall provide for collaboration among European.
Introduction to Radiation Therapy
Odds and Ends on Gantries Rob Edgecock & Akram Kahn Neither of us knew much about gantries ~1 week ago Neither of us know much about gantries now Will.
EuCARD-2 is co-funded by the partners and the European Commission under Capacities 7th Framework Programme, Grant Agreement EuCARD-2, ADS, linacs,
EMMA, BASROC, Hadron Therapy and ADSRs Roger Barlow STFC Cockcroft Review Feb 11 th 2009.
Clinical Application of Carbon Therapy
Hadron Therapy and Grids: Issues and Requirements Ken Peach (Particle Therapy Cancer Research Institute, Oxford) EGI Technical Forum Amsterdam, September.
The Australian Hadron Therapy and Research Facility.
Introduction to NS-FFAGs and EMMA Rob Edgecock STFC Rutherford Appleton Laboratory.
Varian Medical Systems
Presentation By: Jonathan, Marty and Kiran
Introductions Dr Emma Bowers Training Coordinator Talk about: NTC Blended learning Master’s Programme Joe Spoor 1 st year STP trainee Lauren Slater 1 st.
Research and Practical Conference “Accelerators and Radiation technologies for the Futures of Russia” September 2012, Saint-Petersburg Proton Radiation.
April 17, Dejan TrbojevicFFAG07 -Non-Scaling FFAG gantries1 Non-Scaling FFAG Gantries Introduction: Motives: The most challenging problem in the carbon/proton.
Ion Beam Therapy – focus on helium beams Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION.
AccMed Accelerators for Medicine
Understanding Radiation Therapy Lecturer Radiological Science
Radiological Protection in Ion Beam Radiotherapy
Progress in the Application
Accelerator R&D for Future Neutrino Projects
EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
أجهزة العلاج الإشعاعي Clinical Radiation Generator
M. D. Anderson Cancer Center Houston, TX
Figure 5 The biological effects of charged particles
Nanoparticles for enhancing the effectiveness of proton therapy
Principles of Radiation Therapy
Presentation transcript:

BASROC/CONFORM OPEN DAY 2009 At STFC Cockroft Institute Daresbury Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology Century School Particle Therapy Cancer Research Institute, Oxford Physics.

CANCER…..the threat to humanity 40% risk during lifetime…might even increase with global warming (thermodynamics) 40% risk during lifetime…might even increase with global warming (thermodynamics) Surgery, Radiotherapy, Chemotherapy can all be risky and permanently injurious……..no cause for complacency. Surgery, Radiotherapy, Chemotherapy can all be risky and permanently injurious……..no cause for complacency. R/T 12% of NHS cancer budget; its provision regarded as inadequate internationally R/T 12% of NHS cancer budget; its provision regarded as inadequate internationally

Which form of technology would you like used to treat your cancer?

Development of Cancer Radiotherapy Most current radiotherapy uses High energy X-ray beams from linear accelerators or ‘linacs’ Most current radiotherapy uses High energy X-ray beams from linear accelerators or ‘linacs’ These X-ray beams pass through entire thickness of body These X-ray beams pass through entire thickness of body Versatile: rotations, + imaging capabilities Versatile: rotations, + imaging capabilities Modern Linac

Pristine Bragg Peaks of Selected Energies at FHBPTC Courtesy of H. Kooy, Ph.D.

Carbon Ion Beam Profile Bragg peak RBE 5-7 Plateau RBE 1.1  times effect in peak c.f. plateau Peak is spread / scanned & diluted, so RBE is intermediate and varies with position in a patient.

X-Rays or Protons/Ions 150

X-RaysProtons Orbital Rhabdomyosarcoma Courtesy T. Yock, N. Tarbell, J. Adams

International Scene Japan: formed National Institute of Radiation Sciences Japan: formed National Institute of Radiation Sciences Decision to have C ion therapy 1986 Decision to have C ion therapy Commenced 1996 Commenced 1996 Japan Government Science Policy Review noted favourable results and need for science to contribute directly to health of population. Japan Government Science Policy Review noted favourable results and need for science to contribute directly to health of population. Emphasis on cancers that are difficult to treat and for a kinder form of radiotherapy Emphasis on cancers that are difficult to treat and for a kinder form of radiotherapy Japan will soon have 10 facilities, all protons + 3 C ions. Tariff of ~ $ 30,000 per course allowed. Japan will soon have 10 facilities, all protons + 3 C ions. Tariff of ~ $ 30,000 per course allowed.

Countries who used national Physics labs/projects to start Particle Therapy Germany ……GSI….. Heidelberg University Hospital Synchrotron built close to German Cancer Research Institute Germany ……GSI….. Heidelberg University Hospital Synchrotron built close to German Cancer Research Institute France…Orsay University Protons; GANIL (Caen) will host new IBA 400 MeV C cyclotron France…Orsay University Protons; GANIL (Caen) will host new IBA 400 MeV C cyclotron Switzerland: large expansion at PSI (Villigen); development of spot scanning techniques. Switzerland: large expansion at PSI (Villigen); development of spot scanning techniques. Austria…..will use novel CERN cyclolinac system Austria…..will use novel CERN cyclolinac system Italy ….Pavia, synchrotron system Italy ….Pavia, synchrotron system Stanford/USA..plans for new high tech accelerator for C ions; twenty proton centres planned in USA. Stanford/USA..plans for new high tech accelerator for C ions; twenty proton centres planned in USA.

We chose the wrong particle ….the neutron Neutrons would not be chosen today, we need the Bragg Peaks Physical Dose

Kidney Cancer : Stage I, TIa N0 M0 National Institute of Radiological Sciences, Chiba, Japan carbon ions, 80GyE / 16fr. /4wks 治療前 1 year 3 years 4 years 5 years Can radical surgery be avoided? Better cancer screening might create extra need to use physics solutions

Cancer of the oesophagus treated to 72 Gy - hardly any lung exposure in Japan: British plan 54 Gy only Protons two beams British X-rays three beams

Medulloblastoma in a child X-rays Proton particles

The only working model in UK (funded by NHS doctor working during his holiday)

High LET optimum dose per fraction using calculus method Even for protons, treatments might be accelerated; Germany 19# Japan 16, 10, 4, 1 #

Following from Jones & Dale Int J Radiat Oncol Biol & Physics 1998 Cost Model for Radiotherapy Inputs: Cell sensitivity: (dose + dose squared) Cell number Proliferation rate DNA Repair Dose to N Tissue [z] Dose to tumour [d] d=g z g is degree of sparing Cost of achieving low g (reciprocal) Cost per fraction Cost of failure to cure Cost of toxicity Fixed costs Poisson statistics

Japanese Progress in Fractionation 1 treatment only for small lung cancer 1 treatment only for small lung cancer 4 treatments for prostate cancer 4 treatments for prostate cancer Most treatments in treatments over 4 weeks Most treatments in treatments over 4 weeks Cost applied regardless of fractionation Cost applied regardless of fractionation Germany 19 fractions in 19 days at GSI Germany 19 fractions in 19 days at GSI Protons in USA 4-8 (eye); to 38 fractions prostate/skull base. Protons in USA 4-8 (eye); to 38 fractions prostate/skull base.

Expected and achievable benefits Reduce fear of cancer treatment, improved patient experience Reduce fear of cancer treatment, improved patient experience Dose increase to cancer : 1% increase in cancer control per unit increase in dose …..i.e. 15 Gy extra 15% extra control Dose increase to cancer : 1% increase in cancer control per unit increase in dose …..i.e. 15 Gy extra 15% extra control Dose reduction to organs e.g. lung, brain, eye, spine, bowel, bone: leading to reduced or absence of many side effects Dose reduction to organs e.g. lung, brain, eye, spine, bowel, bone: leading to reduced or absence of many side effects Chemotherapy better tolerated Chemotherapy better tolerated Better quality of life, ability to contribute to society etc. Better quality of life, ability to contribute to society etc.

UK Position Member of PARTNER, ULICE & ENVISION EU FP7 grants……totalling ~24 M Euro Member of PARTNER, ULICE & ENVISION EU FP7 grants……totalling ~24 M Euro Occupying a peripheral role…data collection, instrumentation, leadership skills, modelling. Occupying a peripheral role…data collection, instrumentation, leadership skills, modelling. PAMELA – could transform our position to be leader in terms of new technology, clinical efficiency, clinical policies/research, and opportunity for comprehensive radiobiology programme under our own guidance. PAMELA – could transform our position to be leader in terms of new technology, clinical efficiency, clinical policies/research, and opportunity for comprehensive radiobiology programme under our own guidance.

PAMELA Particle Accelerator for MEdicaL Applications Clinical Requirements Clinical Requirements PAMELA – status PAMELA – status Summary Summary EMMA Ring See Smith: WE4PBI01 Electrons – at relativistic velocities approaching speed of light Protons, helium to carbon range of ions – at non-relativistic velocities

Main Clinical Requirements Treatment Plan should be determined by clinical need not limited by Accelerator Technology

Double-helix coil - smart way of creating a cosine-theta magnet Injector systems Gantry/delivery systems RF System

Choices cyclotron Proton Therapy 1 ring NSFFAG Carbon Therapy OR 1 ring NSFFAG Ring 1 NSFFAG ring 2 NSFFAG Proton Therapy Carbon Therapy

Next steps 1. Complete the proton ring design 2. Develop the carbon ring 3. Develop beam transport & gantry 4. Seek component prototype funding Main ring magnets, RF, Kickers, Carbon RFQ Main ring magnets, RF, Kickers, Carbon RFQ 5. Seek machine funding UK Demonstrator for CPT UK Demonstrator for CPT

Primary Liver cancer Primary liver cancer treated by carbon ions Primary liver cancer treated by carbon ions 5 year follow up in cured patient 5 year follow up in cured patient 15 months after RT malignant melanoma malignant melanoma

Some PAMELA work on radiobiology of Dose rate (and so dose duration) Dose rate (and so dose duration) Ion species Ion species Throughput Throughput Dose painting …new features Dose painting …new features + C N

Gantries Heidelberg has huge 300+ ton gantry…… First in world Heidelberg has huge 300+ ton gantry…… First in world French seeking to use cryogenic s/c magnet to halve the weight French seeking to use cryogenic s/c magnet to halve the weight CONFORM system magnets within gantries offers best long term solution to gantry manufacture at lower tonnage, footprint and cost CONFORM system magnets within gantries offers best long term solution to gantry manufacture at lower tonnage, footprint and cost

21 Century School Particle Therapy Cancer Research Institute, Oxford Since January 2009 our aims are to promote:- Education (Public, Professions and Policy Makers) Education (Public, Professions and Policy Makers) Research [Physics, Biology and Medicine] Research [Physics, Biology and Medicine] Investment [NHS, Research Councils, Cancer Charities and Public] Investment [NHS, Research Councils, Cancer Charities and Public] Advanced Technology Ion Treatment Facility in UK and elsewhere - including third world with cost optimisation. Advanced Technology Ion Treatment Facility in UK and elsewhere - including third world with cost optimisation.